India's Minister of Chemicals meets drugmakers

27 August 2006

India's Union Minister for Chemicals and Fertilizers and Steel, Shri Ram Vilas Paswan, held a meeting with the country's drugmakers and relevant trade associations to discuss industry proposals regarding the 2006 National Pharmaceutical Policy.

In a statement, the Indian government said that the drugs industry had put forward a suggested restriction on trade margins of 15% for wholesalers and 35% to retailers for generic drugs. The cap would come into effect from October 2.

Mr Paswan announced the establishment of a 14 person-strong committee with Ministry of Chemicals and Fertilizers and drug industry membership, to "look into the issues raised by the industry including public/private partnership to help BPL [below poverty line] families, concessionary prices for government procurement, competition to contain prices monitoring to replace cost-based price control" and cooperation between the Ministry and the pharmaceutical industry.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight